Non-invasive continuous remote monitoring with structured escalation pathway for Heart Failure

"Over the course of one year, this clinical trial aims to assess the average rate of patient enrollment. There are also three secondary outcomes that will be evaluated: frequency of medication adherence counseling captured in a note within the electronic health record, dietary counseling noted in a similar manner and number of times standard diuretics dosage were escalated clinically."

"Affirmative. The information featured on clinicaltrials.gov reveals that this investigation is actively seeking participants, which initially began recruiting on June 17th 2021 and has since been updated on January 11th 2022. Currently, 45 subjects are required from one site for the study to be considered complete."

"According to information provided on clinicaltrials.gov, this experiment is open for recruitment and was first announced on June 17th 2021 (last edited: January 11th 2022)."

"This clinical trial is seeking 45 individuals aged 18 to 100 who are currently suffering from heart failure. Qualified participants must have received at least one dose of intravenous diuretic medication during their hospitalisation, be inpatients at Evanston Hospital, regularly follow up with the Heart Failure Service Team after discharge, possess a historical record of heart failure symptoms corresponding to NYHA function class II-IV and meet either criteria A (LVEF < 40%), B (40% ≤ LVEF ≤ 50%) or C (50% ≤ LVEF), occupy the top half percentile for 30-day readmission risk as calculated by North"

"This trial is intended for patients aged 18 to 100 years old. Additionally, there are 22 trials for minors and 691 studies specifically designed for individuals 65 or older."